Targeting MRP3 in Pancreatic Cancer In Vitro

Pancreatic cancer is currently one of the most aggressive and resistant cancers. The incidences rates of pancreatic cancer are comparatively low. However, the death rates of pancreatic cancer are within the top 10 of all cancers worldwide. The five-year survival rate is currently 5%, meaning that 95...

Full description

Bibliographic Details
Main Author: Dantzic, Daniel Deveraux Estevan (Author)
Other Authors: Li, Yan (Contributor), Merien, Fabrice (Contributor), Liu, Dong-Xu (Contributor)
Format: Others
Published: Auckland University of Technology, 2020-06-16T00:33:28Z.
Subjects:
Online Access:Get fulltext